Supply of Omeprazole Extended-Release
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract with the Department of Defense Medical Supply Chain Pharm FSA involves the manufacture and procurement of Omeprazole Extended-Release for prime contractors. The supplier must ensure the pharmaceutical product adheres to a non-extendable 18-month shelf-life under Type I Code K and follows Medical Marking Standard No. 1. All production must occur in FDA-regulated facilities using packaging that complies with FED-STD-313, with final delivery handled as FOB Destination. The project is categorized under NAICS code 325412 and is designated for performance at Fort Bliss, Texas. Interested parties must respond by September 21, 2026, following the posting date of September 14, 2026.
General Info
Agency
NAICS
Place of Performance
FORT BLISS, TX, 79918-2527, USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-5070.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
OMEPRAZOLE EXTENDED-RE
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
